MINT MINT, Dpt of Biology, University of Rome Tor Vergata MINT http://mint.bio.uniroma2.it/mint url>http://mint.bio.uniroma2.it/mint/ https://mint.bio.uniroma2.it MINT-[0-9]+ https://mint.bio.uniroma2.it/index.php/results-interactions/?id=${ac} The Molecular INTeraction database (MINT) is a relational database designed to store interactions between biological molecules. http://mint.bio.uniroma2.it Site-directed mutagenesis of alanine-382 of human antithrombin III. Site-directed mutagenesis of alanine-382 of human antithrombin III. FEBS letters 1991 imex curation Austin RC., Rachubinski RA., Blajchman MA. Rare diseases - Interactions investigated in the context of Rare genetic disease 24-May-2021: Contacted by IntAct-Help. Only protein-protein interactions imex curation in vitro In vitro comigration in sds comigration in sds page comigration in sds weight autoradiogra molecular weight estimation by autoradiography weight autoradiogra Austin RC., Rachubinski RA., Blajchman MA. Rare diseases - Interactions investigated in the context of Rare genetic disease Accepted 2021-APR-26 AT 13:45 BST AT 13:45 BST by MGT FEBS letters 1991 Only protein-protein interactions imex curation imex curation p01008-pro_0000032489 Antithrombin-III Serpin C1 PRO0309 SERPINC1 AT3 protein protein human Homo sapiens Human HGSPVDICTAKPRDIPMNPMCIYRSPEKKATEDEGSEQKIPEATNRRVWELSKANSRFATTFYQHLADSKNDNDNIFLSPLSISTAFAMTKLGACNDTLQQLMEVFKFDTISEKTSDQIHFFFAKLNCRLYRKANKSSKLVSANRLFGDKSLTFNETYQDISELVYGAKLQPLDFKENAEQSRAAINKWVSNKTEGRITDVIPSEAINELTVLVLVNTIYFKGLWKSKFSPENTRKELFYKADGESCSASMMYQEGKFRYRRVAEGTQVLELPFKGDDITMVLILPKPEKSLAKVEKELTPEVLQEWLDELEEMMLVVHMPRFRIEDGFSLKEQLQDMGLVDLFSPEKSKLPGIVAEGRDDLYVSDAFHKAFLEVNEEGSEAAASTAVVIAGRSLNPNRVTFKANRPFLVFIREVPLNTIIFMGRVANPCVK 33 464 2DD065FEBA9738B5 p00734-pro_0000028160 Prothrombin F2 Coagulation factor II protein protein human Homo sapiens Human ANTFLEEVRKGNLERECVEETCSYEEAFEALESSTATDVFWAKYTACETARTPRDKLAACLEGNCAEGLGTNYRGHVNITRSGIECQLWRSRYPHKPEINSTTHPGADLQENFCRNPDSSTTGPWCYTTDPTVRRQECSIPVCGQDQVTVAMTPRSEGSSVNLSPPLEQCVPDRGQQYQGRLAVTTHGLPCLAWASAQAKALSKHQDFNSAVQLVENFCRNPDGDEEGVWCYVAGKPGDFGYCDLNYCEEAVEEETGDGLDEDSDRAIEGRTATSEYQTFFNPRTFGSGEADCGLRPLFEKKSLEDKTERELLESYIDGRIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFGE 44 622 66DD4325E7CB9F07 tat-1 1 3 unspecified role unspecified role neutral component neutral component purified purified 2 unspecified role unspecified role neutral component neutral component cell lysate cell lysate 35S radiolabel 35s radiolabel 35s radiolabel 35S s35 radiolabelled S35 s35 radiolabelled 35S S35 undetermined undetermined sequence position undetermined undetermined undetermined sequence position undetermined P01008-PRO_0000032489:p.Ala382Ile mutation decreasing strength mutation decreasing interaction strength mutation decreasing strength certain certain sequence position certain certain certain sequence position certain A I Thu Apr 22 13:08:34 BST 2021 This feature has been corrected as a result of our quality control procedures. The original label was 'PRO_0000032489:p.Ala382Ile' P01008-PRO_0000032489:p.Ala382Gln mutation decreasing strength mutation decreasing interaction strength mutation decreasing strength certain certain sequence position certain certain certain sequence position certain A Q Thu Apr 22 13:40:20 BST 2021 This feature has been corrected as a result of our quality control procedures. The original label was 'PRO_0000032489:p.Ala382Gln' P01008-PRO_0000032489:p.Ala382Thr mutation disrupting strength mutation disrupting interaction strength mutation disrupting strength certain certain sequence position certain certain certain sequence position certain A T Thu Apr 22 10:28:37 BST 2021 This feature has been corrected as a result of our quality control procedures. The original label was 'PRO_0000032489:p.Ala382Thr' P01008-PRO_0000032489:p.Ala382Lys mutation disrupting strength mutation disrupting interaction strength mutation disrupting strength certain certain sequence position certain certain certain sequence position certain A K Thu Apr 22 11:43:06 BST 2021 This feature has been corrected as a result of our quality control procedures. The original label was 'PRO_0000032489:p.Ala382Lys' P01008-PRO_0000032489:p.Ala382Leu mutation decreasing strength mutation decreasing interaction strength mutation decreasing strength certain certain sequence position certain certain certain sequence position certain A L Thu Apr 22 13:22:45 BST 2021 This feature has been corrected as a result of our quality control procedures. The original label was 'PRO_0000032489:p.Ala382Leu' P01008-PRO_0000032489:p.Ala382Val mutation decreasing strength mutation decreasing interaction strength mutation decreasing strength certain certain sequence position certain certain certain sequence position certain A V Thu Apr 22 10:55:39 BST 2021 This feature has been corrected as a result of our quality control procedures. The original label was 'PRO_0000032489:p.Ala382Val' P01008-PRO_0000032489:p.Ala382Gly mutation decreasing strength mutation decreasing interaction strength mutation decreasing strength certain certain sequence position certain certain certain sequence position certain A G Thu Apr 22 12:59:24 BST 2021 This feature has been corrected as a result of our quality control procedures. The original label was 'PRO_0000032489:p.Ala382Gly' rabit-reticulocyte Oryctolagus cuniculus reticulocyte reticulocyte Reticulocytes physical association physical association Table 1